Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...

Biotech investors have rarely united so strongly against a Food and Drug Administration official as they did against Vinay ...

Now, it’s worth noting Stock Advisor’s total average return is 949 % — a market-crushing outperformance compared to 190% for ...

Both of these players are leaders in their fields.

Flagship Pioneering-backed Alltrna is once again laying off staff, this time reducing its workforce by 19 people. | Flagship ...

We're also trying to make sure we look back at some of the trades that are still alive so we can keep you posted. We wrote ...

Investors are increasingly wary of the rare-disease space, spooked by a regulatory shift.

T-cell engager (TCE) specialist Candid Therapeutics has entered into a reverse merger agreement with Rallybio that will allow ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter, ...

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

Building a big nest egg for your post-work life by buying stocks is very possible, but it requires patience, investing in the ...